HIV-1 evolution driven by intracellular defenses
HIV-1 evolution driven by intracellular defenses
批准号:
7369738
负责人:
Viviana A Simon
金额:
$35.47万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2010-02-28
关键词:
AddressAllelesAnti-Retroviral AgentsAntiviral AgentsBinding SitesBiological AssayBoxingCellsComplementary DNACytidineCytidine DeaminaseDeaminaseDeaminationDinucleoside PhosphatesDrug resistanceEnzymesEventEvolutionFluorescenceGene SilencingGenomeHIVHIV-1IndividualInduced MutationInfectionMapsMediatingMutagenesisMutationNucleotidesNumbersPathogenesisPathogenicityPatternPeripheral Blood Mononuclear CellPharmaceutical PreparationsPlayPolymerasePropertyProteinsProvirusesRNA-Directed DNA PolymeraseRateResistanceRetroviridaeReverse TranscriptionRoleStructureTestingVariantViralVirusbasefitnessin vivomutantpressurepreventresearch studyvif Gene Productsvif Genes
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Retroviruses have devised a number of strategies to evade cellular mechanisms aimed at preventing retroviral infection.
HIV-1 expressesVif, a protein that counteracts the antiviral activity of the cytidine deaminases APOBEC3G and APOBEC3F.
The nucleotide composition of the HIV-1 genome suggests, however, that protection from host-mediated viral cDNA
deamination may not be absolute. In preliminary studies, we showed that vif genes encoding proteins that fail to degrade
APOBEC3G, APOBEC3F or both can be detected in vivo. The loss of Vif function was mapped to single nucleotide
substitutions. These studies indicate that natural variation in Vif function may profoundly impact the extent and direction of
viral sequence evolution within HIV-1 infected individuals.
The experiments proposed herein will determine the extent to which host mechanisms aimed to prevent retroviral
infection, in fact, contribute to viral diversification and pathogenesis. We will analyze the fitness of viruses expressing Vif
proteins that are closely related but differ in their ability to neutralize APOBEC3G or APOBEC3F activities. We will also test if
variation in Vif function may be beneficial for viral adaptation under certain circumstances (e.g., in the presence of
antiretroviral drugs) by determining whether cytidine deamination by APOBEC3G or APOBEC3F selects for certain drug
resistance mutations. The pattern of hypermutations associated with partial protection from cytidine deamination will be
correlated to HIV fitness. Since APOBEC3 enzymes induce hypermutations in different dinucleotide contexts the
understanding of how activity against one enzyme but not the other is maintained is relevant for viral evolution. We will
conduct structure function studies to determine whether domains other than the Vif SOCS box motif are necessary and
essential for Vif mediated specific neutralization of APOBEC3 enzymes. Finally, we will assess the impact of reverse
transcription and APOBECS-driven mutagenesis on loss of Vif function. We will determine the rate of Vif inactivation as
result of either reverse transcriptase or cytidine deamination induced mutations on a single cell level using assays based on
fluorescence tagged APOBEC3G degradation. Variation in Vif function may influence the pathogenicity of HIV-1 by rendering
its genome more or less resistant to deaminase activity and these studies have the potential to reveal how Vif mediated
protection from cytidine deamination is modulated in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10549476
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2023
-
负责人:Viviana A Simon
-
依托单位:
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
-
批准号:10549479
-
项目类别:
-
资助金额:$104.19万
-
财政年份:2023
-
负责人:Viviana A Simon
-
依托单位:
Dissecting the drivers of persistent SARS-CoV-2 infections
-
批准号:10736007
-
项目类别:
-
资助金额:$83.13万
-
财政年份:2023
-
负责人:Viviana A Simon
-
依托单位:
Clinical Core
-
批准号:10435233
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2022
-
负责人:Viviana A Simon
-
依托单位:
HIV latency driven microgliosis
-
批准号:10700148
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2022
-
负责人:Viviana A Simon
-
依托单位:
HIV latency driven microgliosis
-
批准号:10618696
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2022
-
负责人:Viviana A Simon
-
依托单位:
Clinical Core
-
批准号:10595625
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2022
-
负责人:Viviana A Simon
-
依托单位:
Preventing CD4+ T memory cells from becoming HIV reservoirs
-
批准号:9914204
-
项目类别:
-
资助金额:$59.33万
-
财政年份:2018
-
负责人:Viviana A Simon
-
依托单位:
Targeting HIV persistence in CD4+ T memory stem cells
-
批准号:9321252
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2016
-
负责人:Viviana A Simon
-
依托单位:
HTLV-1 antagonists of HIV restriction factors
-
批准号:8651884
-
项目类别:
-
资助金额:$21.01万
-
财政年份:2013
-
负责人:Viviana A Simon
-
依托单位:
HTLV-1 antagonists of HIV restriction factors
-
批准号:8466151
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2013
-
负责人:Viviana A Simon
-
依托单位:
Genomic Determinants of Intrinsic Antiviral Host Defenses
-
批准号:8470533
-
项目类别:
-
资助金额:$40.07万
-
财政年份:2010
-
负责人:Viviana A Simon
-
依托单位:
Genomic Determinants of Intrinsic Antiviral Host Defenses
-
批准号:8660599
-
项目类别:
-
资助金额:$42.61万
-
财政年份:2010
-
负责人:Viviana A Simon
-
依托单位:
Genomic Determinants of Intrinsic Antiviral Host Defenses
-
批准号:8012140
-
项目类别:
-
资助金额:$44.75万
-
财政年份:2010
-
负责人:Viviana A Simon
-
依托单位:
Genomic Determinants of Intrinsic Antiviral Host Defenses
-
批准号:8277253
-
项目类别:
-
资助金额:$42.62万
-
财政年份:2010
-
负责人:Viviana A Simon
-
依托单位:
Genomic Determinants of Intrinsic Antiviral Host Defenses
-
批准号:8075524
-
项目类别:
-
资助金额:$42.61万
-
财政年份:2010
-
负责人:Viviana A Simon
-
依托单位:
HIV-1 evolution driven by intracellular defenses
-
批准号:7846471
-
项目类别:
-
资助金额:$1.7万
-
财政年份:2009
-
负责人:Viviana A Simon
-
依托单位:
HIV-1 evolution driven by intracellular defenses
-
批准号:7069062
-
项目类别:
-
资助金额:$5.59万
-
财政年份:2005
-
负责人:Viviana A Simon
-
依托单位:
HIV Evolution Driven by Intracellular Defenses
-
批准号:8697000
-
项目类别:
-
资助金额:$61.93万
-
财政年份:2005
-
负责人:Viviana A Simon
-
依托单位:
HIV-1 evolution driven by intracellular defenses
-
批准号:7006413
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2005
-
负责人:Viviana A Simon
-
依托单位:
海外基金